{
    "ticker": "ETX",
    "name": "Eton Pharmaceuticals, Inc.",
    "description": "Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative therapeutics for patients, with a particular emphasis on unique formulations and delivery methods for existing drugs. Founded in 2017, Eton is committed to addressing unmet medical needs by enhancing the efficacy and safety of established medications. The company operates by leveraging its proprietary technology platform to create improved versions of existing drugs, thereby increasing their therapeutic benefit and patient compliance. Eton's product pipeline includes a range of formulations that cater to various therapeutic areas, including pediatrics and rare diseases. The company is dedicated to ensuring that patients have access to high-quality medications that meet their specific needs. Eton has a robust strategy for engaging with healthcare professionals, patients, and payers to facilitate the adoption of its products. By focusing on innovative solutions, Eton Pharmaceuticals aims to make a significant impact on patient care and outcomes while driving growth and value for its stakeholders.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Lake Forest, Illinois, USA",
    "founded": "2017",
    "website": "https://etonpharma.com",
    "ceo": "Sean O'Connor",
    "social_media": {
        "twitter": "https://twitter.com/EtonPharma",
        "linkedin": "https://www.linkedin.com/company/eton-pharmaceuticals/"
    },
    "investor_relations": "https://etonpharma.com/investor-relations/",
    "key_executives": [
        {
            "name": "Sean O'Connor",
            "position": "CEO"
        },
        {
            "name": "Mike McCarthy",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Specialty Pharmaceuticals",
            "products": [
                "Eton's Drug Products",
                "Innovative Formulations"
            ]
        }
    ],
    "seo": {
        "meta_title": "Eton Pharmaceuticals, Inc. | Innovative Drug Formulations",
        "meta_description": "Explore Eton Pharmaceuticals, Inc., a leader in specialty pharmaceuticals focused on developing innovative formulations for unmet medical needs.",
        "keywords": [
            "Eton Pharmaceuticals",
            "Specialty Pharmaceuticals",
            "Innovative Drug Formulations",
            "Therapeutics",
            "Pharmaceutical Company"
        ]
    },
    "faq": [
        {
            "question": "What is Eton Pharmaceuticals known for?",
            "answer": "Eton Pharmaceuticals is known for developing innovative drug formulations and addressing unmet medical needs in specialty pharmaceuticals."
        },
        {
            "question": "Who is the CEO of Eton Pharmaceuticals?",
            "answer": "Sean O'Connor is the CEO of Eton Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Eton Pharmaceuticals headquartered?",
            "answer": "Eton Pharmaceuticals is headquartered in Lake Forest, Illinois, USA."
        },
        {
            "question": "What types of products does Eton Pharmaceuticals offer?",
            "answer": "Eton Pharmaceuticals offers specialty pharmaceuticals with innovative formulations for various therapeutic areas."
        },
        {
            "question": "When was Eton Pharmaceuticals founded?",
            "answer": "Eton Pharmaceuticals was founded in 2017."
        }
    ],
    "competitors": [
        "PFE",
        "ABBV",
        "VRTX",
        "AMGN"
    ],
    "related_stocks": [
        "JNJ",
        "GILD",
        "MRNA",
        "BIIB"
    ]
}